Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical is sailing against a few new headwinds. So far its financial performance hasn't been severely impacted.

What's Up Next for Intuitive Surgical Stock?

Intuitive Surgical's da Vinci robots help doctors perform surgeries with fewer errors. Procedure growth is impressive, driving revenue for the company's instruments and accessories.

This Robotics-Assisted Surgery Leader Just Posted Stellar Earnings. Is It A Buy?

Intuitive Surgical (ISRG) is making strides in the robotic-assisted surgery market with its existing and new launches. However, macro challenges are likely to continue to hurt its performance.

Intuitive Surgical (ISRG) Rises 5% Post Earnings: What's Next?

Robotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line, but that's not the case at the moment. Robots have yet to replace human surgeons.

Why Intuitive Surgical Stock is Dominating the Medical Sector

e.l.f. Beauty

Healthcare and beauty spending tend to remain resilient in a wide range of economic environments. Intuitive Surgical has a vast moat, and growth is accelerating despite near-term challenges beyond its control.

The Ultimate Growth Stocks to Buy With $1,000 Right Now

Crocs

Regardless of market fluctuations, it's always a good time to invest in quality companies. Intuitive Surgical has a simple but effective business model that is driving impressive growth.

These 2 Magnificent Growth Stocks Are Set to Soar This Summer and Beyond

Vertex Pharmaceuticals

Johnson & Johnson hasn't performed that well in the past decade. By contrast, Vertex Pharmaceuticals and Intuitive Surgical have been exceptional.

Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?

Airbnb

A leader in surgical robotics and an innovative travel specialist are both faring well in the current environment. Intuitive Surgical is raking in robust profits and revenue growth from its flagship products.

Got $1,000? 2 No-Brainer Growth Stocks to Buy and Hold Forever

Microsoft

Symbotic Inc

If you are looking for AI-related stocks you can buy and hold forever, look no further than this list. The stocks on this list are applying AI, and the application of AI counts.

3 AI Stocks That You Can Buy and Hold Forever

Cigna

GE HealthCare Technologies Inc

HCA Healthcare

Eli Lilly

McKesson

Thermo Fisher Scientific

There are a whole host of reasons to invest in healthcare stocks over the long term. The United States has an aging population.

Healthy Profits: 7 Healthcare Stocks to Build a Lifetime of Wealth

Micron Technology

Shopify

As I'm sure everyone reading this is aware, artificial intelligence, or AI, has been quite a volatile sector in the recent past. All indicators suggest this will continue in the near to semi-long-term future.

What Are the Hottest AI Stocks Right Now? 3 Top Picks

Intuitive Surgical has an impressive international growth opportunity with hospitals. Growth and valuation expansion have combined to fuel investment returns.

Is Intuitive Surgical Stock a Buy?

Intuitive Surgical's procedure volume in one key category is declining. However, the medical device specialist continues to record excellent financial results.

Should Investors Worry About These 7 Words From Intuitive Surgical's CEO?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet

Coinbase

Loar Holdings Inc

Even after some recent correction, the S&P 500 index is not far from all-time highs. With the possibility of rate cuts, there is a reason to remain bullish on equities.

3 Overvalued Growth Stocks to Sell Before They Correct by 30%

Abbott Labs

Healthcare stocks are generally good bets, thanks to a rapidly growing population of older adults in the U.S. and other developed economies. Abbott Laboratories is growing sales at a high-single-digit annual percentage and offers a quarterly dividend.

Better Buy: Abbott Laboratories vs. Intuitive Surgical

Double digit growth is back for the maker of da Vinci.

Bull of the Day: Intuitive Surgical (ISRG)

Emerson Electric

NVIDIA

UiPath

Rockwell Automation

Stryker

Teradyne

Robotics are set to revolutionize industries ranging from transportation to healthcare. And America will be a major growth market.

7 American Robotics Stocks to Buy if You're Betting on Trump 2024

Does Intuitive Surgical, Inc. (ISRG) have what it takes to be a top stock pick for momentum investors? Let's find out.

Intuitive Surgical, Inc. (ISRG) is a Great Momentum Stock: Should You Buy?

Here is how Intuitive Surgical, Inc. (ISRG) and biote Corp. (BTMD) have performed compared to their sector so far this year.

Are Medical Stocks Lagging Intuitive Surgical (ISRG) This Year?

Shares of Intuitive Surgical ISRG surged 9.3% last Friday, after the company announced second-quarter results. The share price touched an all-time high of $456.81 and also closed at a record high of $455.01.

Intuitive Surgical (ISRG) Hits All-Time High: Will It Go Higher?

Intuitive Surgical's NASDAQ: ISRG stock bucked the broad-market selloff because of its operational quality, performance, outlook, and balance sheet, which has absolutely nothing wrong with it. The B/S highlights for Q2 include a 490 basis point increase in cash and securities and the net cash position.

Intuitive Surgical Stock Outperforms Market: Highs on the Horizon

ABB Ltd

Boston Scientific

iRobot

iRhythm Technologies

Robotics stocks are a good investment as the industry is rapidly progressing.  Robotics stocks have great potential to increase their revenues in the future due to the increased usage of robots in different industries due to technological developments.

7 Robotics Stocks That Could Grow Your Wealth

After reaching an important support level, Intuitive Surgical, Inc. (ISRG) could be a good stock pick from a technical perspective. ISRG surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.

News for Intuitive Surgical Stock (ISRG)